chr11-63598091-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001128203.2(PLAAT3):c.88G>A(p.Asp30Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,613,376 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001128203.2 missense
Scores
Clinical Significance
Conservation
Publications
- lipodystrophy, familial partial, type 9Inheritance: AR Classification: LIMITED Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLAAT3 | NM_001128203.2 | c.88G>A | p.Asp30Asn | missense_variant | Exon 3 of 5 | ENST00000415826.3 | NP_001121675.1 | |
PLAAT3 | NM_007069.3 | c.88G>A | p.Asp30Asn | missense_variant | Exon 2 of 4 | NP_009000.2 | ||
PLAAT3 | XM_011544741.2 | c.133G>A | p.Asp45Asn | missense_variant | Exon 2 of 4 | XP_011543043.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152190Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000954 AC: 24AN: 251476 AF XY: 0.000118 show subpopulations
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1461186Hom.: 0 Cov.: 30 AF XY: 0.0000536 AC XY: 39AN XY: 726936 show subpopulations
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74336 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.88G>A (p.D30N) alteration is located in exon 2 (coding exon 2) of the PLA2G16 gene. This alteration results from a G to A substitution at nucleotide position 88, causing the aspartic acid (D) at amino acid position 30 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at